Longevity / Aging Supplement

GlyNAC (glycine + N-acetylcysteine)

Grade and summary pending review Evidence Grade Strength of published clinical evidence — not a safety rating or a recommendation. How to read this

Dimension Scores

Human Outcome

•

Biomarker Relevance

•

Signal Source Quality

•

Organ Specificity

•

Interaction Certainty

•

Translational Maturity

•

Per-dimension evidence strength is part of the full analysis Unlock full analysis

No indication-level signals recorded yet. The grade above has not been decomposed, so it should be read as a whole-compound assessment rather than a claim about any one indication.

Evidence Summary

The dramatic 'reverses aging hallmarks' headlines come from one very small trial at a single lab. A larger independent trial did NOT confirm the main result (it missed its primary glutathione endpoint). The evidence does not support the strong claims, though it may help a specific high-oxidative-stress subgroup.

Safety Considerations

Strong claims rest on one small single-lab trial that failed independent replication. NAC without glycine has been linked in animal studies to faster growth of pre-existing tumors (animal data only). Talk to a doctor if you have a cancer history.

Evidence Signals (0)

🔒

Create a free account to see signal-level evidence grades.

Create a free account

Products Containing GlyNAC (glycine + N-acetylcysteine)

No commercial products are currently listed for this molecule.

This evidence profile reflects publicly available research as of October 22, 2026. Evidence grades may change as new research is published. ClinEvident grades the quality of published evidence — it does not evaluate the efficacy of any specific commercial product.